WEATHER ALERT

Pharmacare to cover quit-smoking aid

Advertisement

Advertise with us

Smokers who are trying to kick the habit now have cheaper access to a treatment option.

Read this article for free:

or

Already have an account? Log in here »

To continue reading, please subscribe:

Subscribe and receive a limited-edition Free Press branded hat or tote.

Digital Subscription

One year of digital access for only $205*

  • Enjoy unlimited reading on winnipegfreepress.com
  • Read the E-Edition, our digital replica newspaper
  • Access News Break, our award-winning app
  • Play interactive puzzles

*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.

To continue reading, please subscribe:

Add Free Press access to your Brandon Sun subscription for only an additional

$1 for the first 4 weeks*

  • Enjoy unlimited reading on winnipegfreepress.com
  • Read the E-Edition, our digital replica newspaper
  • Access News Break, our award-winning app
  • Play interactive puzzles
Start now

*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.

Hey there, time traveller!
This article was published 28/11/2011 (5348 days ago), so information in it may no longer be current.

Smokers who are trying to kick the habit now have cheaper access to a treatment option.

The province added the drug Champix to its drug formulary last Thursday.

“Champix is proven to be an effective treatment option for adult smokers who want to quit,” said Healthy Living Minister Jim Rondeau in a release. “Making it available now will mean that people can get it in time to help them with their New Year’s resolution to quit smoking.”

TIMES COLONIST ARCHIVES
TIMES COLONIST ARCHIVES

With its listing in the drug formulary, the drug is eligible for benefit coverage under pharmacare, if prescribed by a physician. A 12-week course of therapy would cost about $350.

 

Report Error Submit a Tip